5 Keys to Optimizing Biopharma Business Development

To find the right partnerships, biopharmaceutical companies must evaluate hundreds of external innovations and negotiate complex deals, all while managing internal resources efficiently.

Biopharma companies today are under intense pressure to find the most promising assets and quickly replenish their pipelines. To succeed, the partnering, external innovation, and transaction teams must find new, better ways of working.

We have made it our mission to understand the pains and challenges of biopharma partnering. We work together with our clients to continuously improve our software and find new ways to help optimize their business development activities.

5 keys hero

Please complete the form below

All fields marked with a * are required.

Inova_5 Keys to Optimizing Biopharma Business Development_page1
Inova_5 Keys to Optimizing Biopharma Business Development_page2
Inova_5 Keys to Optimizing Biopharma Business Development_page3
Preview Whitepaper

Discover 5 best practices used by top biopharma companies to optimize their business development activities

  • Get an overview of current partnering trends in the biopharma industry.
  • Discover common pain points that every biopharmaceutical company deals with as they search for and evaluate potential collaborations.
  • Learn 5 best practices used by top biopharma companies to partner successfully.

About Inova

Inova accelerates partnering for the future of medicine. Our cloud-based solutions help life science companies manage their biopharma opportunities more efficiently. They find all their partnering information in one place, track their deals and alliances easily and report on their pipeline and activities in seconds.
We have also developed strategic partnerships that make data from the 20 biggest biopharma events automatically available in Inova, providing our users with always up-to-date company and contact information. Over 160 life science companies, including 60% of the top 50 pharmaceutical companies and many midsize pharma and innovative biotechs already use Inova.